Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 1,2811,300 of 20,252 grants

Active NON-SBIR/STTR RPGS
Collagen Signaling in Pancreatic Cancer
NATIONAL CANCER INSTITUTE Henry Ford Health + Michigan State Unive... United States 2024 – 2029

Abstract Pancreatic Ductal Adenocarcinoma (PDA) is the 3rd most common cause of cancer death in the United States. One of the primary pathological features of PDA is the dense netw...

$6.31M
USD
Active NON-SBIR/STTR RPGS
ID3 regulation of tissue-infiltrating T cells mediating graft-versus-host disease and leukemia rejection
NATIONAL CANCER INSTITUTE Hackensack University Medical Center United States 2024 – 2029

PROJECT SUMMARY Graft-versus-host disease (GVHD) and the sequelae of immunosuppression have been a major barrier to the success of allogeneic hematopoietic stem cell transplantatio...

$7.53M
USD
Active NON-SBIR/STTR RPGS
Dissecting and Targeting MAPK - PPARG Crosstalk in Bladder Cancer
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2024 – 2029

Bladder cancer (BC) accounts for 80,000 new cancer diagnoses and 20,000 deaths annually in the US. Recent large-scale studies have comprehensively mapped the genetic landscape of B...

$4.98M
USD
Completed NON-SBIR/STTR RPGS
Deciphering the Impact of ZNF397-deficiency in Promoting TET2-driven Epigenetic Rewiring, Lineage Plasticity, and Therapy Resistance in Prostate Cancer
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2024 – 2024

PROJECT SUMMARY Phenotypic plasticity and epigenetic reprogramming stand as two noteworthy cancer hallmarks. Lineage plasticity, in particular, has been recognized as a key mechani...

$82.7K
USD
Active NON-SBIR/STTR RPGS
Image-guided Histotripsy System for Complete, Uniform, and Non-Invasive Ablation of Heterogeneous Osteosarcoma Tumors
NATIONAL CANCER INSTITUTE Virginia Polytechnic Inst and St Univ United States 2024 – 2028

Summary The goal of this project is to develop a novel histotripsy device for non-invasive treatment of heterogeneous osteosarcoma tumors (OS). OS are malignant bone tumors that de...

$6.28M
USD
Active NON-SBIR/STTR RPGS
Therapy of PARP inhibitor-associated myeloid neoplasms in ovarian cancer patients
NATIONAL CANCER INSTITUTE Mayo Clinic Rochester United States 2024 – 2029

ABSTRACT Therapy-related myeloid neoplasms (tMNs), including myelodysplastic syndrome (MDS) and acute myeloid leuk- emia (AML), are severe, often rapidly fatal bone marrow disorder...

$4.67M
USD
Active NON-SBIR/STTR RPGS
Clinical Neuroimmunology of CCL3 in Brain Tumors
NATIONAL CANCER INSTITUTE Duke University United States 2024 – 2029

ABSTRACT: Malignant primary brain tumors represent the most frequent cause of cancer death in children and young adults and account for more deaths than cancer of the kidney or mel...

$3.24M
USD
Active NON-SBIR/STTR RPGS
Suppressing the Co-chaperone UNC45A reprograms the immunosuppressive tumor microenvironment to fight Cancer
NATIONAL CANCER INSTITUTE Augusta University United States 2024 – 2029

Abstract Breast cancer remains one of the leading causes of death among women in the US. When available, targeted therapies have significantly improved the outcomes for breast canc...

$6.07M
USD
Active NON-SBIR/STTR RPGS
Acceptance and Commitment Therapy for Patient Fatigue Interference and Caregiver Burden in Advanced Gastrointestinal Cancer
NATIONAL CANCER INSTITUTE Indiana University Indianapolis United States 2024 – 2029

Project Summary/Abstract Fatigue interference with activities, mood, and cognition is one of the most prevalent and distressing concerns of advanced gastrointestinal cancer patient...

$6.46M
USD
Active NON-SBIR/STTR RPGS
Structural Racism and Cardiovascular Outcomes Among Cancer Survivors
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT Among individuals who survive ≥5-years from a cancer diagnosis, cardiovascular disease (CVD) is the leading cause of death. Black adults with cancer have t...

$5.95M
USD
Active NON-SBIR/STTR RPGS
Cyanobacteria, cyanotoxins, and liver cancer development
NATIONAL CANCER INSTITUTE University of Hawaii At Manoa United States 2024 – 2029

Liver cancer remains a major challenge in the U.S. with over 41,000 new cases and 30,000 deaths annually. Hepatocellular carcinoma (HCC), the primary form of liver cancer, develops...

$6.21M
USD
Completed OTHER RESEARCH-RELATED
American Urological Association (AUA) Urologic Oncology Research Symposium on "Implementation Science: Translating Clinical Studies into Practice
NATIONAL CANCER INSTITUTE American Urological Association United States 2024 – 2025

2024 AUA OFFICE OF RESEARCH UROLOGIC ONCOLOGY RESEARCH SYMPOSIUM “Implementation Science: Translating Clinical Studies into Practice” PROJECT SUMMARY/ABSTRACT This application requ...

$150K
USD
Completed OTHER RESEARCH-RELATED
23rd Midwest DNA Repair Symposium
NATIONAL CANCER INSTITUTE University of Louisville United States 2024 – 2025

Abstract The 23rd Midwest DNA Repair Symposium (MDRS) will take place in Louisville, KY on June 1-2, 2024 at the Health Science Campus of the University of Louisville. The MDRS sta...

$150K
USD
Active NON-SBIR/STTR RPGS
Metabolic flux analysis and PDX models to understand therapeutic vulnerabilities following inhibition of Ref-1 redox signaling in pancreatic cancer
NATIONAL CANCER INSTITUTE Indiana University Indianapolis United States 2024 – 2026

ABSTRACT Pancreatic ductal adenocarcinoma (PDAC) exhibits an extraordinary resistance to therapy and often manifests as metastatic disease. It is characterized by hypoxia, a dense...

$271.1K
USD
Active NON-SBIR/STTR RPGS
Supplement to Promote Diversity:Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous system
NATIONAL CANCER INSTITUTE University of California-Irvine United States 2024 – 2026

No Changes to the Abstract Chemotherapy-related cognitive impairment (CRCI, chemobrain), chemotherapy-induced peripheral neuropathy (CIPN) and gait changes are debilitating side-ef...

$183.2K
USD
Active NON-SBIR/STTR RPGS
Reducing Lung Cancer Risk among Appalachian Women Using Community‐Engaged Intervention Research
NATIONAL CANCER INSTITUTE Pennsylvania State University, The United States 2024 – 2027

PROJECT SUMMARY Appalachian women are at high risk for lung cancer. Lung cancer is the leading cause of cancer-related death for women in the US, including the Appalachian region....

$2.49M
USD
Completed OTHERS
MATCHMAKERS: Large-scale generation of TCR-pMHC pairs from naturally occurring sources.
NATIONAL CANCER INSTITUTE Technical University of Munich Germany 2024 – 2025

Abstract Understanding how T cell receptors (TCRs) see tumor antigens presented by MHCs is necessary to fully understand how the immune system recognizes tumor antigens, and to rea...

$1.92M
USD
Completed OTHERS
PROSPECT - Microbiome Studies. (PATHWAYS, RISK FACTORS, AND MOLECULES TO PREVENT EARLY-ONSET COLORECTAL TUMOURS)
NATIONAL CANCER INSTITUTE University of Trento Italy 2024 – 2025

ABSTRACT Our vision is to unravel and ultimately reverse the intricate network of causal factors throughout the life course that disrupts biological homeostasis to promote colorect...

$1.34M
USD
Completed OTHERS
MATCHMAKERS
NATIONAL CANCER INSTITUTE Netherlands Cancer Institute Netherlands 2024 – 2025

Abstract Understanding how T cell receptors (TCRs) see tumor antigens presented by MHCs is necessary to fully understand how the immune system recognizes tumor antigens, and to rea...

$1.68M
USD
Completed OTHERS
PROTECT - Harnessing Protein Degradation for Advancing Childhood Tumors
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2024 – 2025

ABSTRACT Background Survival rates for children with solid tumors, including brain, have largely plateaued over the past three decades making them the most common cause of disease-...

$1.05M
USD